Clinical Trial

Lung Cancer Screening Program in Mexico

Study acronym: DETECTO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2025 (before its estimated March 24, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective study aims to detect early-stage lung cancer using low-dose computed tomography (LDCT) in Mexicans aged 50 or older who are current or former heavy smokers, non-smokers exposed to significant wood smoke, or diagnosed with COPD. Annual LDCT, spirometry, and serum biomarker tests will be conducted over 3 years, and a follow-up lasting up to 10 years.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-30; most recent amendment 2025-12-17.
Trial Details
NCT Number NCT06535451
Lead Sponsor Instituto Nacional de Cancerologia de Mexico
Conditions Lung Cancer
Enrollment 1,000 participants
Start Date 2022-03-24
Primary Completion 2026-03-24 (estimated)
Study Completion 2027-03-24 (estimated)
Updated on ClinicalTrials.gov 2025-12-24